Skip to main content
Top
Published in: Journal of Neuro-Oncology 1/2018

01-08-2018 | Clinical Study

Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results Program, 2000–2014

Authors: Erin C. Peckham-Gregory, Roberto E. Montenegro, David A. Stevenson, David H. Viskochil, Michael E. Scheurer, Philip J. Lupo, Joshua D. Schiffman

Published in: Journal of Neuro-Oncology | Issue 1/2018

Login to get access

Abstract

Background

Malignant peripheral nerve sheath tumors (MPNSTs) are rare tumors, generally high-grade, and comprise ~ 5–10% of soft tissue sarcomas. Over two-thirds of MPNSTs metastasize, and upwards of 40% clinically recur. Etiologic risk factors for MPNSTs are historically understudied. There is evidence to suggest MPNST incidence differs across racial/ethnic groups in pediatric populations. Therefore, we sought to estimate differences in MPNST incidence by race/ethnicity among all ages in the United States.

Methods

Incidence data were obtained from the Surveillance, Epidemiology, and End Results (SEER-18) Program, 2000–2014. Race/ethnicity was categorized as: White; Black; Asian; Other; and Latino/a (“Spanish–Hispanic–Latino”). Latino/a included all races, while all other categories excluded those identified as Latino/a. Age-adjusted incidence rate ratios (IRR) and 95% confidence intervals (CIs) were generated in SEER-STAT (v8.3.4). We estimated incidence rates among all ages, and among those diagnosed < 25 and ≥ 25 years.

Results

MPNST cases were abstracted from SEER-18 (n = 1047). Among all age groups, Blacks experienced an elevated incidence of MPNSTs compared to Whites (IRRBlacks = 1.26, 95% CI 1.04–1.50). Asian and Latinos/as experienced lower incidences compared to Whites (IRRAsians = 0.78, 95% CI 0.61–0.99; IRRLatinos/as = 0.84, 95% CI 0.69–1.02). In subgroup analyses, no statistically significant associations with MPNSTs were identified among cases diagnosed < 25 years of age, whereas the associations observed among all age groups were prominent among those diagnosed ≥ 25 years of age.

Conclusions

Incidence rates of MPNSTs were highest in Blacks compared to Whites and other minority groups. This study suggests specific patterns exist in terms of race/ethnicity and age at diagnosis of MPNSTs.
Literature
2.
go back to reference Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, Isambert N, Thariat J, Linassier C, Bertucci F, Bay JO, Bellesoeur A, Penel N, Le Guellec S, Filleron T, Chevreau C (2016) Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO). Eur J Cancer 56:77–84. https://doi.org/10.1016/j.ejca.2015.12.015 CrossRefPubMed Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, Isambert N, Thariat J, Linassier C, Bertucci F, Bay JO, Bellesoeur A, Penel N, Le Guellec S, Filleron T, Chevreau C (2016) Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO). Eur J Cancer 56:77–84. https://​doi.​org/​10.​1016/​j.​ejca.​2015.​12.​015 CrossRefPubMed
4.
go back to reference Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS (2014) Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. Pediatr Blood Cancer 61(11):1955–1960. https://doi.org/10.1002/pbc.25149 CrossRefPubMed Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS (2014) Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. Pediatr Blood Cancer 61(11):1955–1960. https://​doi.​org/​10.​1002/​pbc.​25149 CrossRefPubMed
7.
go back to reference Vasconcelos RATD, Coscarelli PG, Alvarenga RP, Acioly MA (2017) Malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1. Arq Neuropsiquiatr 75:366–371CrossRefPubMed Vasconcelos RATD, Coscarelli PG, Alvarenga RP, Acioly MA (2017) Malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1. Arq Neuropsiquiatr 75:366–371CrossRefPubMed
9.
go back to reference Szudek J, Birch P, Riccardi VM, Evans DG, Friedman JM (2000) Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol 19(4):429–439CrossRefPubMed Szudek J, Birch P, Riccardi VM, Evans DG, Friedman JM (2000) Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol 19(4):429–439CrossRefPubMed
10.
go back to reference King AA, Debaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93(5):388–392CrossRefPubMed King AA, Debaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93(5):388–392CrossRefPubMed
12.
go back to reference Wanebo JE, Malik JM, Vandenberg SR, Wanebo HJ, Driesen N, Persing JA (1993) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 71(4):1247–1253CrossRefPubMed Wanebo JE, Malik JM, Vandenberg SR, Wanebo HJ, Driesen N, Persing JA (1993) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 71(4):1247–1253CrossRefPubMed
14.
go back to reference Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat database: incidence—SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub (2000–2014) < Katrina/Rita population adjustment>—linked to county attributes—Total U.S., 1969–2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based on the November 2016 submission. Surveillance, Epidemiology, and End Results (SEER) Program (http://​www.​seer.​cancer.​gov) SEER*Stat database: incidence—SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub (2000–2014) < Katrina/Rita population adjustment>—linked to county attributes—Total U.S., 1969–2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based on the November 2016 submission.
17.
go back to reference Shabihkhani M, Telesca D, Movassaghi M, Naeini YB, Naeini KM, Hojat SA, Gupta D, Lucey GM, Ontiveros M, Wang MW, Hanna LS, Sanchez DE, Mareninov S, Khanlou N, Vinters HV, Bergsneider M, Nghiemphu PL, Lai A, Liau LM, Cloughesy TF, Yong WH (2017) Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. J Neuro-oncol 132(2):351–358. https://doi.org/10.1007/s11060-017-2377-0 CrossRef Shabihkhani M, Telesca D, Movassaghi M, Naeini YB, Naeini KM, Hojat SA, Gupta D, Lucey GM, Ontiveros M, Wang MW, Hanna LS, Sanchez DE, Mareninov S, Khanlou N, Vinters HV, Bergsneider M, Nghiemphu PL, Lai A, Liau LM, Cloughesy TF, Yong WH (2017) Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. J Neuro-oncol 132(2):351–358. https://​doi.​org/​10.​1007/​s11060-017-2377-0 CrossRef
22.
go back to reference D’Agostino AN, Soule EH, Miller RH (1963) Sarcomas of the peripheral nerves and somatic soft tissues associated with multiple neurofibromatosis (Von Recklinghausen’s disease). Cancer 16(8):1015–1027.CrossRefPubMed D’Agostino AN, Soule EH, Miller RH (1963) Sarcomas of the peripheral nerves and somatic soft tissues associated with multiple neurofibromatosis (Von Recklinghausen’s disease). Cancer 16(8):1015–1027.CrossRefPubMed
Metadata
Title
Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results Program, 2000–2014
Authors
Erin C. Peckham-Gregory
Roberto E. Montenegro
David A. Stevenson
David H. Viskochil
Michael E. Scheurer
Philip J. Lupo
Joshua D. Schiffman
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-018-2842-4

Other articles of this Issue 1/2018

Journal of Neuro-Oncology 1/2018 Go to the issue